Our prediction model incorporating BMI, hemoglobin, eGFR, ALT, and TyG index as covariates showed good predictive performance regarding the presence of sonographic NAFLD in CKD patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.